Friday, 12 Jun 2020 10:31 AM MYT
TOKYO, June 12 ― Fujifilm Holdings Corp will spend US$928 million to double capacity at a drug manufacturing facility in Denmark, which it has pledged to use in producing Covid-19 treatments, as the Japanese company steps up its pivot towards healthcare. The investment expands Fujifilm's presence as a global contract development and manufacturing organisation , which supplies other companies in the pharma industry. Fujifilm started to diversify from cameras and office equipment and into healthcare more than a decade ago.